AI Engines For more Details: Perplexity Kagi Labs You
Hypertension: Cyclopenthiazide is primarily used as an antihypertensive agent to lower blood pressure in individuals with hypertension. Thiazide diuretics like cyclopenthiazide work by increasing the excretion of sodium and water through the kidneys, leading to a reduction in blood volume and decreased vascular resistance. This helps to lower blood pressure and reduce the risk of cardiovascular complications associated with hypertension, such as heart attacks, strokes, and kidney disease.
Edema: Cyclopenthiazide may also be used in the management of edema (fluid retention) associated with various medical conditions, including congestive heart failure, liver cirrhosis, and kidney disorders (such as nephrotic syndrome). By promoting diuresis (increased urine production) and reducing fluid accumulation in the body tissues, cyclopenthiazide helps alleviate symptoms of edema such as swelling in the legs, ankles, and abdomen, and improves overall fluid balance.
Dosage and Administration: Cyclopenthiazide is typically administered orally in the form of tablets or capsules. The dosage and frequency of administration depend on factors such as the severity of hypertension or edema, the individual patient's response to treatment, and any underlying medical conditions. Cyclopenthiazide is usually taken once daily in the morning or as directed by the healthcare provider. It may be taken with or without food, but it is essential to take it consistently to achieve optimal therapeutic effects.
Side Effects: Common side effects of cyclopenthiazide may include increased urination, electrolyte imbalances (such as hypokalemia or hyponatremia), dehydration, dizziness, lightheadedness, weakness, muscle cramps, nausea, vomiting, diarrhea, and allergic reactions (such as rash or itching). Rare but serious side effects may include severe electrolyte disturbances, kidney dysfunction, pancreatitis, and blood disorders. Patients should be monitored regularly for side effects during cyclopenthiazide therapy, and treatment should be adjusted as needed based on individual response and tolerance.
Interactions: Cyclopenthiazide may interact with other medications, supplements, or substances, potentially affecting their efficacy or increasing the risk of side effects. It is essential to inform the healthcare provider about all other medications and supplements being taken, including prescription drugs, over-the-counter medications, vitamins, and herbal products, to avoid potential drug interactions.
Precautions: Cyclopenthiazide should be used with caution in patients with certain medical conditions, including kidney impairment, liver disease, diabetes mellitus, gout, electrolyte imbalances, and hypersensitivity to sulfonamide-derived medications. It may not be suitable for use in pregnant or breastfeeding women, and caution should be exercised in elderly patients due to the increased risk of adverse effects.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Flavonifractor plautii | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.6 | 0.6 | |
Acne | 0.3 | -0.3 | |
ADHD | 2.8 | 0.2 | 13 |
Age-Related Macular Degeneration and Glaucoma | 0.4 | 0.4 | |
Allergic Rhinitis (Hay Fever) | 1.1 | 2.1 | -0.91 |
Allergies | 4.7 | 3.1 | 0.52 |
Allergy to milk products | 1.5 | 0.7 | 1.14 |
Alopecia (Hair Loss) | 0.7 | 0.7 | |
Alzheimer's disease | 3.8 | 3.6 | 0.06 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.3 | 1 | 1.3 |
Ankylosing spondylitis | 2.2 | 0.9 | 1.44 |
Anorexia Nervosa | 1.1 | 1.9 | -0.73 |
Antiphospholipid syndrome (APS) | 0.7 | 0.7 | |
Asthma | 3.3 | 2.5 | 0.32 |
Atherosclerosis | 1.8 | 0.8 | 1.25 |
Atrial fibrillation | 2.5 | 0.6 | 3.17 |
Autism | 4.8 | 5.2 | -0.08 |
Autoimmune Disease | 0.4 | 0.4 | 0 |
Barrett esophagus cancer | 0.3 | 0 | 0 |
benign prostatic hyperplasia | 0 | 0.3 | 0 |
Biofilm | 0.5 | 0.5 | |
Bipolar Disorder | 0.9 | 1 | -0.11 |
Brain Trauma | 0.5 | 1.2 | -1.4 |
Breast Cancer | 0 | 0 | |
Cancer (General) | 0.6 | 2.1 | -2.5 |
Carcinoma | 2.1 | 1.9 | 0.11 |
Celiac Disease | 1.9 | 3.1 | -0.63 |
Cerebral Palsy | 1.2 | 1.1 | 0.09 |
Chronic Fatigue Syndrome | 3.8 | 3.6 | 0.06 |
Chronic Kidney Disease | 1.9 | 0.7 | 1.71 |
Chronic Lyme | 0.1 | 0.4 | -3 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.4 | 0.6 | -0.5 |
Chronic Urticaria (Hives) | 0.4 | 0.9 | -1.25 |
Coagulation / Micro clot triggering bacteria | 0.1 | 0.8 | -7 |
Cognitive Function | 1.5 | 0.7 | 1.14 |
Colorectal Cancer | 2.7 | 1 | 1.7 |
Constipation | 0.9 | 0.3 | 2 |
Coronary artery disease | 0.8 | 1.7 | -1.13 |
COVID-19 | 6.8 | 8.7 | -0.28 |
Crohn's Disease | 3.3 | 3.8 | -0.15 |
Cushing's Syndrome (hypercortisolism) | 0.3 | -0.3 | |
cystic fibrosis | 0 | 1.6 | 0 |
d-lactic acidosis (one form of brain fog) | 0 | 0 | |
deep vein thrombosis | 0.7 | 0.9 | -0.29 |
Denture Wearers Oral Shifts | 0.8 | 0.8 | |
Depression | 6.2 | 5.1 | 0.22 |
Dermatomyositis | 0 | 0.3 | 0 |
Eczema | 0.4 | 1.5 | -2.75 |
Endometriosis | 1.2 | 1.3 | -0.08 |
Eosinophilic Esophagitis | 0.4 | -0.4 | |
Epilepsy | 1.8 | 1.6 | 0.13 |
erectile dysfunction | 0.3 | 0.3 | 0 |
Fibromyalgia | 1.6 | 0.7 | 1.29 |
Functional constipation / chronic idiopathic constipation | 3 | 2.4 | 0.25 |
gallstone disease (gsd) | 1.8 | 0.7 | 1.57 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.8 | 1.1 | -0.38 |
Generalized anxiety disorder | 1 | 1.5 | -0.5 |
giant cell arteritis | 0 | 0 | |
Glioblastoma | 0 | 0 | |
Gout | 2.1 | 0.3 | 6 |
Graves' disease | 1.6 | 2.2 | -0.38 |
Gulf War Syndrome | 0.3 | 2.1 | -6 |
Halitosis | 0.6 | 0 | 0 |
Hashimoto's thyroiditis | 2.8 | 1 | 1.8 |
Heart Failure | 1.3 | 1.5 | -0.15 |
hemorrhagic stroke | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 0.5 | 0.3 | 0.67 |
High Histamine/low DAO | 0.2 | 0.8 | -3 |
hypercholesterolemia (High Cholesterol) | 0.3 | 0.5 | -0.67 |
hyperglycemia | 0.9 | 1.6 | -0.78 |
Hyperlipidemia (High Blood Fats) | 0.7 | 0.2 | 2.5 |
hypersomnia | 0.4 | -0.4 | |
hypertension (High Blood Pressure | 2.7 | 5 | -0.85 |
Hypothyroidism | 0.2 | 0.7 | -2.5 |
Hypoxia | 1.1 | 1.1 | |
IgA nephropathy (IgAN) | 0.9 | 2.8 | -2.11 |
Inflammatory Bowel Disease | 4 | 6.5 | -0.63 |
Insomnia | 1.3 | 2.3 | -0.77 |
Intelligence | 0.6 | 0.6 | |
Intracranial aneurysms | 1 | 0.2 | 4 |
Irritable Bowel Syndrome | 5.4 | 3 | 0.8 |
ischemic stroke | 2.3 | 0.4 | 4.75 |
Liver Cirrhosis | 4.2 | 2.7 | 0.56 |
Long COVID | 4.7 | 6.3 | -0.34 |
Low bone mineral density | 0.4 | -0.4 | |
Lung Cancer | 0.5 | 1.6 | -2.2 |
Lymphoma | 0 | 0 | |
Mast Cell Issues / mastitis | 0 | 0.8 | 0 |
ME/CFS with IBS | 0.6 | 2 | -2.33 |
ME/CFS without IBS | 0.5 | 1.4 | -1.8 |
membranous nephropathy | 0 | 0 | |
Menopause | 2 | 0.3 | 5.67 |
Metabolic Syndrome | 3.9 | 5.5 | -0.41 |
Mood Disorders | 7 | 4.3 | 0.63 |
multiple chemical sensitivity [MCS] | 0.7 | 0.2 | 2.5 |
Multiple Sclerosis | 3.5 | 2.7 | 0.3 |
Multiple system atrophy (MSA) | 1.1 | 1 | 0.1 |
myasthenia gravis | 0 | 0.1 | 0 |
neuropathic pain | 0.1 | 1.7 | -16 |
Neuropathy (all types) | 0.6 | 0.5 | 0.2 |
neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.3 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.7 | 4.4 | -0.63 |
NonCeliac Gluten Sensitivity | 1.6 | 0.6 | 1.67 |
Obesity | 6 | 5 | 0.2 |
obsessive-compulsive disorder | 3.1 | 1.8 | 0.72 |
Osteoarthritis | 1.1 | 1.3 | -0.18 |
Osteoporosis | 1.3 | 1.5 | -0.15 |
pancreatic cancer | 0.2 | 0 | 0 |
Parkinson's Disease | 4.4 | 3.3 | 0.33 |
Polycystic ovary syndrome | 3 | 2.5 | 0.2 |
Postural orthostatic tachycardia syndrome | 0 | 0.3 | 0 |
Premenstrual dysphoric disorder | 0.7 | 0.7 | |
primary biliary cholangitis | 0.6 | 0.2 | 2 |
Primary sclerosing cholangitis | 1.6 | 1.4 | 0.14 |
Psoriasis | 3 | 0.9 | 2.33 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.5 | 2.3 | 0.96 |
Rosacea | 0.9 | 0.1 | 8 |
Schizophrenia | 5 | 2.2 | 1.27 |
scoliosis | 0.1 | 0.8 | -7 |
sensorineural hearing loss | 0.1 | 0.1 | |
Sjögren syndrome | 1.7 | 1.8 | -0.06 |
Sleep Apnea | 1.3 | 0.7 | 0.86 |
Slow gastric motility / Gastroparesis | 1.1 | 0.3 | 2.67 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.7 | 0.6 | 0.17 |
Stress / posttraumatic stress disorder | 1.2 | 1.6 | -0.33 |
Systemic Lupus Erythematosus | 1.7 | 1.6 | 0.06 |
Tic Disorder | 0.7 | 0.7 | 0 |
Tourette syndrome | 0.5 | 0.3 | 0.67 |
Type 1 Diabetes | 2.7 | 3 | -0.11 |
Type 2 Diabetes | 4.4 | 4.8 | -0.09 |
Ulcerative colitis | 2.6 | 4.4 | -0.69 |
Unhealthy Ageing | 2.1 | 0.9 | 1.33 |
Vitiligo | 1.7 | 0.8 | 1.13 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]